Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma

European Journal of Cancer(2022)10.1016/j.ejca.2022.03.032Source: DataRank Database

Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma is a research paper published in European Journal of Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 43 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access43 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 8.61)OA: bronzeTopics (49)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Tamara Prodanov ORCID,Leah Meuter,Annika M.A. Berends ORCID,Nicole Bechmann ORCID,Georgiana Constantinescu ORCID

Live enrichment

PubMed:35500459 OpenAlex:https://openalex.org/W4225164047

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

FWCI

8.61

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: CC BY NC ND

journalhttp://www.ejcancer.com/article/S0959804922001800/pdf

publisherhttp://www.ejcancer.com/article/S0959804922001800/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0959804922001800?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0959804922001800?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ejca.2022.03.032

Fields of Study

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

Adrenal Gland NeoplasmsHumansMetanephrineParagangliomaPheochromocytomaRetrospective StudiesNeoplasms, Second Primary

Keywords

MedicinePheochromocytomaParagangliomaMetanephrinesNormetanephrineInternal medicineDiseaseRetrospective cohort studyOncologyGastroenterologyUrologyPathologySurvival10265 Clinic for Endocrinology and DiabetologyAdrenal Gland NeoplasmsRadboud University Medical Center610 Medicine & healthMALIGNANT PHEOCHROMOCYTOMAMetastasesDOPAMINERadboudumc 16: Vascular damage RIHS: Radboud Institute for Health SciencesHIF2-ALPHAHumans1306 Cancer ResearchInternal Medicine - Radboud University Medical CenterHEAD610 Medicine & healthMetanephrineRetrospective StudiesRadboudumc 16: Vascular damage RIMLS: Radboud Institute for Molecular Life SciencesUTILITYPredictorsNeoplasms, Second PrimaryMethoxytyramine2730 OncologyBEHAVIOR

Sustainable Development Goals

SDG 0: Good health and well-being